The Complete Guide to Ketamine Microdosing for Depression & Anxiety

What Is Ketamine Microdosing?

Ketamine microdosing refers to the practice of taking very low, sub-perceptual doses of ketamine—typically between 5 mg and 30 mg administered sublingually (under the tongue)—on a regular schedule to promote gradual improvements in mood, cognition, and overall mental health. Unlike standard therapeutic ketamine sessions that use higher doses to produce noticeable dissociative effects, microdosing aims to harness ketamine’s neuroplasticity-promoting properties without altering your day-to-day perception or ability to function normally.

To understand microdosing, it helps to see where it fits on the ketamine dosing spectrum. Standard therapeutic dosing—the approach used by most at-home ketamine providers and IV clinics—typically ranges from 100 mg to 300 mg sublingually, or around 0.5 mg/kg when administered intravenously. At these levels, patients often experience significant dissociation, altered perception of time, and sometimes vivid mental imagery. While effective for many people, these sessions require setting aside dedicated time, remaining in a supervised or safe environment, and recovering afterward. At the highest end of the spectrum, psychedelic-dose ketamine (sometimes called “high dose” or “K-hole” dosing) produces profound dissociative and mystical experiences and is used in specialized clinical settings.

Microdosing sits at the opposite end of this spectrum. At 5–30 mg sublingually, most patients report no dissociative effects whatsoever. There is no “trip,” no need to clear your schedule, and no recovery period. Instead, the medication works subtly in the background, modulating glutamate signaling and encouraging the brain to form new neural connections over time. Many advocates of ketamine microdosing compare it to taking a daily antidepressant—it becomes part of your routine rather than a discrete therapeutic event.

Sublingual Administration

Nearly all ketamine microdosing programs use sublingual troches (lozenges) or rapidly dissolving tablets. The medication is placed under the tongue and held there for 10–15 minutes, allowing absorption through the oral mucosa directly into the bloodstream. Sublingual bioavailability is approximately 25–35%, meaning a 20 mg troche delivers roughly 5–7 mg of active ketamine to the system. This route is preferred for microdosing because it allows precise dosing at very low levels, can be done at home, and avoids the need for IV access or intramuscular injections.

Daily vs. Intermittent Protocols

Microdosing protocols generally fall into two categories. Daily protocols involve taking a micro-dose every day or nearly every day, building a consistent baseline of glutamate modulation. The Joyous model popularized this approach, prescribing daily low-dose ketamine as a kind of next-generation antidepressant. Intermittent protocols might involve dosing every other day, three times per week, or on a specific schedule determined by the prescribing clinician. Some providers start patients on daily microdosing and then transition to intermittent schedules once improvement stabilizes. The right protocol depends on individual response, symptom severity, and the clinical judgment of the prescribing provider.

How Ketamine Microdosing Works

Ketamine is fundamentally different from traditional antidepressants like SSRIs, SNRIs, or tricyclics. While those medications primarily target the serotonin and norepinephrine systems and require weeks to produce effects, ketamine acts on the glutamate system—the brain’s primary excitatory neurotransmitter pathway—and can begin promoting neuroplastic changes much more rapidly.

NMDA Receptor Modulation at Sub-Perceptual Doses

At its core, ketamine is an NMDA (N-methyl-D-aspartate) receptor antagonist. Even at micro-doses, ketamine temporarily blocks a subset of NMDA receptors, particularly those on GABAergic interneurons. This produces a disinhibition effect that results in a brief surge of glutamate in the prefrontal cortex and hippocampus. This glutamate surge activates AMPA receptors, which in turn trigger a cascade of intracellular signaling that leads to the release of brain-derived neurotrophic factor (BDNF)—a protein critical for the growth and maintenance of neurons.

Neuroplasticity Promotion

BDNF release activates the mTOR (mechanistic target of rapamycin) pathway, stimulating the formation of new synaptic connections between neurons. In patients with depression, chronic stress has often degraded synaptic density in key brain regions. Ketamine—even at micro-doses taken regularly—may help reverse this synaptic atrophy by encouraging the brain to build new connections. This is sometimes called synaptogenesis, and it represents a fundamentally different mechanism than simply increasing serotonin availability (as SSRIs do).

The Glutamate System vs. Serotonin

Traditional antidepressants like fluoxetine (Prozac) or sertraline (Zoloft) work by blocking the reuptake of serotonin, making more of it available in the synaptic cleft. This approach helps many patients but has significant limitations: it takes 4–8 weeks to reach full effect, produces side effects like sexual dysfunction and weight gain, and fails entirely for roughly 30% of patients with treatment-resistant depression. Ketamine’s glutamate-based mechanism offers an alternative pathway that works faster, operates through a different neurotransmitter system, and may help precisely those patients for whom serotonin-based treatments have failed.

Potential Benefits of Ketamine Microdosing

While research on ketamine microdosing specifically is still emerging, clinical observations and patient reports suggest several potential benefits:

Depression Relief

The most well-documented benefit of ketamine at any dose is its antidepressant effect. Microdosing may provide sustained, gradual relief from depressive symptoms by maintaining consistent glutamate modulation and BDNF-driven neuroplasticity. Patients often report a gentle lifting of the “heaviness” associated with depression over the first few weeks of treatment.

Anxiety Reduction

Many patients report that ketamine microdosing helps reduce generalized anxiety, social anxiety, and anticipatory anxiety. The glutamate system plays a role in fear circuitry and anxious rumination, and regular modulation may help quiet overactive anxiety pathways.

Improved Neuroplasticity

Regular micro-doses may maintain an elevated baseline of neuroplastic activity, making the brain more adaptable to therapeutic interventions like cognitive behavioral therapy, lifestyle changes, and new coping strategies. Some patients describe feeling more “mentally flexible” or “unstuck.”

Treatment-Resistant Depression

For patients who have not responded to multiple SSRIs, SNRIs, or other standard treatments, ketamine microdosing offers a fundamentally different mechanism of action. Because it targets the glutamate system rather than serotonin, it can work even when serotonin-based treatments have failed.

Rapid Onset

Even at micro-doses, ketamine’s effects tend to manifest faster than traditional antidepressants. While SSRIs may take 6–8 weeks, many microdosing patients report noticing improvements within 1–2 weeks, with continued improvement over the first month.

Mood Stabilization Between Larger Doses

Some patients use microdosing as a “bridge” strategy between larger therapeutic sessions. For example, if you do a higher-dose ketamine session once every two weeks, daily microdosing in between may help maintain and extend the antidepressant effects, reducing the “crash” that some patients experience as the effects of a single session wane.

Microdosing Protocols

There is no single “right” way to microdose ketamine. Protocols vary by provider, patient response, and clinical judgment. Here are the most common approaches currently in use:

Daily Low-Dose Protocol

Popularized by providers like Joyous, this protocol involves taking a micro-dose (typically 5–15 mg sublingual) every day. The rationale is that daily dosing maintains consistent glutamate modulation, similar to how daily SSRI use maintains serotonin levels. Patients typically take their dose in the evening or before bed to minimize any mild drowsiness during waking hours. The daily model treats ketamine microdosing as a maintenance medication rather than an intermittent intervention.

Intermittent Dosing Protocol

Some providers prescribe microdoses on an intermittent schedule—every other day, three days per week, or even twice weekly. This approach accounts for ketamine’s relatively long-lasting effects on neuroplasticity: a single dose may promote synaptogenesis for 48–72 hours after administration. Intermittent protocols may be preferred for patients who experience any residual effects (even mild ones) from daily dosing, or as a cost-saving measure.

Titration Schedules

Most responsible providers start at the lowest effective dose and titrate upward based on patient response. A typical titration might look like:

How Providers Determine Dose

A good ketamine provider will consider multiple factors when determining your microdose: body weight, symptom severity, prior medication history, sensitivity to medications, and ongoing response. Regular check-ins (typically weekly or biweekly in the first month) allow the provider to make adjustments. This is a collaborative process—your subjective experience matters enormously.

The Importance of Medical Supervision

Ketamine is a Schedule III controlled substance, and even at micro-doses, it should only be used under the guidance of a licensed medical professional. Self-dosing or obtaining ketamine without a prescription is both illegal and dangerous. A supervised program ensures proper dosing, monitors for adverse effects, checks for drug interactions, and provides clinical accountability.

Is Microdosing Right for You?

Ketamine microdosing isn’t the right approach for everyone. Understanding who benefits most can help you make an informed decision.

Who May Benefit Most from Microdosing

• Patients with mild to moderate depression or anxiety who want a gentler approach than high-dose sessions
• People who are sensitive to medications and prefer to start at the lowest possible dose
• Those seeking an alternative to SSRIs who want to try a glutamate-based approach
• Patients using microdosing as a bridge between higher-dose ketamine sessions
• Individuals who cannot take time off for the recovery period associated with standard doses
• People new to ketamine who want to ease into treatment gradually

Who Should Consider Standard Dosing Instead

• Patients with severe treatment-resistant depression who need the more powerful effects of standard doses
• Those in acute crisis who need rapid, significant symptom relief
• Patients who have tried microdosing and found it insufficient
• People who value the introspective experience of higher-dose ketamine sessions for psychological processing

Providers That Support Ketamine Microdosing

Several telehealth providers now offer programs that include or focus on ketamine microdosing. Here’s how they compare:

Provider Comparison at a Glance

Safety Considerations for Microdosing

While ketamine microdosing has a favorable safety profile compared to higher doses, it’s important to be informed about potential risks and considerations.

Side Effects at Micro-Doses

At true microdose levels (under 15–20 mg), most patients report minimal to no side effects. When they do occur, common side effects include:

• Mild drowsiness (most common; usually resolves within 30–60 minutes)
• Slight nausea (uncommon at micro-doses; more common with higher amounts)
• Minor changes in perception (rare at true microdose levels)
• Vivid dreams (reported by some patients, especially with evening dosing)
• Metallic taste (from sublingual administration; temporary)

Drug Interactions

Ketamine can interact with several medication classes. Always inform your prescribing provider about all medications you take, including:

• Benzodiazepines (may reduce ketamine’s effectiveness)
• Opioids (combined sedation risk)
• MAOIs (potential blood pressure interaction)
• Lamotrigine (may reduce ketamine’s antidepressant effect)
• Alcohol (avoid on dosing days)

When to Talk to Your Doctor

Contact your provider immediately if you experience: significant dissociation at your prescribed dose, increased depression or suicidal thoughts, persistent nausea or vomiting, unusual heart rate changes, or any symptom that concerns you. A good provider will be responsive and adjust your protocol accordingly.

Microdosing vs. Standard Dose Ketamine

Understanding the differences between these approaches helps you choose the right path for your needs.

The reality is that many patients benefit from both approaches at different points in their treatment journey. Starting with microdosing and titrating upward if needed is a sensible strategy—but only if your provider supports that flexibility. A provider like Kalm Health allows you to begin at any dose level and adjust as your needs evolve, giving you the full spectrum of options under one program.

Getting Started with Ketamine Microdosing

If you’re considering ketamine microdosing, here’s a step-by-step guide to getting started safely and effectively:

1. Research and self-assess. Understand your symptoms, treatment history, and what you hope to achieve. Ketamine microdosing is most appropriate for depression, anxiety, and related conditions that haven’t fully responded to other treatments.
2. Choose a provider. Select a licensed telehealth provider that offers microdosing protocols. Prioritize providers that offer free consultations, transparent pricing, and dose flexibility in case you need to adjust your protocol later.
3. Complete your medical evaluation. Your provider will review your medical history, current medications, and mental health symptoms to determine if you’re a candidate for ketamine microdosing. This step is non-negotiable for safe treatment.
4. Receive your medication. If approved, your prescription will be filled by a licensed compounding pharmacy and shipped to your home. Sublingual troches or tablets will arrive with dosing instructions.
5. Begin your protocol. Start at the dose your provider prescribes (typically 5–10 mg). Take your dose at the same time each day, usually in the evening. Hold the troche under your tongue for the full recommended time (10–15 minutes).
6. Track your symptoms. Keep a daily journal or use a mood-tracking app to record your symptoms, energy levels, sleep quality, and any side effects. This data is invaluable for dose adjustments.
7. Check in with your provider. Most programs schedule check-ins at 1 week, 2 weeks, and monthly thereafter. Share your tracking data and be honest about what’s working and what isn’t.
8. Adjust as needed. Based on your response, your provider may increase your dose, change your frequency, or recommend transitioning to a different dosing strategy. The goal is finding your optimal protocol.

What to Expect: First Week

During the first week, most patients notice very little change—and that’s expected. You may experience mild drowsiness after your first few doses as your body adjusts. Some patients report slightly improved sleep quality within the first few days. Don’t be discouraged if you don’t feel dramatic improvement immediately; microdosing is designed to work gradually.

What to Expect: First Month

By weeks 2–4, many patients begin noticing subtle but meaningful shifts: slightly more motivation, reduced intensity of negative thought patterns, better emotional resilience, and improved sleep. These changes are often easier for close friends or family to notice than the patient themselves. This is where symptom tracking becomes especially valuable—looking back at your data often reveals improvement that felt invisible in the moment.

Frequently Asked Questions